US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.97

+0.10130.35%

Post-market: 28.91-0.0577-0.20%16:10 EDT

Volume:479

Turnover:13.81K

Market Cap:1.01M

PE:- -

High:28.97

Open:28.80

Low:28.80

Close:28.87

52wk High:29.88

52wk Low:24.32

Shares:35.00K

Float Shares:35.00K

Volume Ratio:0.60

T/O Rate:1.37%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Oruka Therapeutics Names Todd Edwards Chief Commercial Officer

Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating

MT Newswires Live

Is AbbVie (ABBV) Fairly Valued As New Lung Cancer Data Impresses?

Simply Wall St.

Hims & Hers’ weight-loss plans draw penalties by Visa, Bloomberg reports

ANI Pharma Appoints Henry Gosebruch to Board of Directors

EstÉE Lauder : Berenberg Raises Target Price to $92 from $84

THOMSON REUTERS

Hims & Hers (HIMS) Stock Looks Like A Bargain After A 396% Run

Simply Wall St.

Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken

Market Chatter: Hims & Hers Health Faces Nearly $75,000 Bill From Card Disputes

MT Newswires Live

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study

AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch

AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now

Estee Lauder is Maintained at Equal-Weight by Barclays

Estée Lauder Announces Q3 2026 Distribution of R$ 0.05 Per Unit, Payable Sept. 21

Hims & Hers Health (HIMS) Lifts Guidance As Scrutiny Builds, Is The Stock Fully Valued?

Simply Wall St.

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of USD 691,808 in Common Shares

AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study

Estee Lauder's Fiscal 2027 Guidance Achievable as Turnaround Continues, RBC Says

MT Newswires Live

Estée Lauder Analysts Boost Their Forecasts After Better-Than-Expected Q2 Results

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/GLAM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":28.9677,"timestamp":1788206400000,"preClose":28.8664,"halted":0,"volume":479,"hourTrading":{"tag":"盘后","latestPrice":28.91,"preClose":28.9677,"latestTime":"16:10 EDT","volume":4,"amount":115.8708,"timestamp":1788207004338,"change":-0.0577,"changeRate":-0.001992,"amplitude":0},"delay":0,"changeRate":0.0035092702934900765,"floatShares":35000,"shares":35000,"eps":0,"marketStatus":"Not Yet Opened","change":0.1013,"latestTime":"08-31 16:00:00 EDT","open":28.8,"high":28.9677,"low":28.8,"amount":13812,"amplitude":0.00581,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":0,"adr":0,"exchange":"CBOE","adjPreClose":28.8664,"nav":28.84,"aum":1009400,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.91,"preClose":28.9677,"latestTime":"16:10 EDT","volume":4,"amount":115.8708,"timestamp":1788207004338,"change":-0.0577,"changeRate":-0.001992,"amplitude":0},"volumeRatio":0.602364,"impliedVol":0.143,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":35000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.602364,"shares":35000,"dividePrice":0,"high":28.9677,"amplitude":0.00581,"preClose":28.8664,"low":28.8,"week52Low":24.3178,"pbRate":"--","week52High":29.88,"institutionHeld":0,"latestPrice":28.9677,"eps":0,"divideRate":0,"volume":479,"delay":0,"ttmEps":0,"open":28.8,"prevYearClose":25.82,"prevWeekClose":28.8664,"prevMonthClose":27.9767,"prevQuarterClose":27.6454,"fiveDayClose":29.073,"twentyDayClose":28.3642,"sixtyDayClose":24.4439},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662205703","title":"Oruka Therapeutics Names Todd Edwards Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205703","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205703?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601676,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics names Todd Edwards chief commercial officerOruka Therapeutics named Todd Edwards chief commercial officer, effective Aug. 24, 2026.Edwards joins from Arcutis Biotherapeutics, where ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL6VDQwY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211327993.USD","BCDF","IDNA","IE00BN0W2W23.USD","LU1291159041.SGD","RXL","LU2129689431.USD","ABBV","BK4550","LU1718418525.SGD","VHT","LU1496350502.SGD","LU2125909247.SGD","XLV","PJP","FHLC","AGNG","GLAM","LU0820561909.HKD","SG9999015945.SGD","LU0738911758.USD","PPH","SG9999014021.USD","ARQT","IYH","LU1934455277.USD","LU0456855351.SGD","TRUH","IE00B3PB1722.GBP","IE00B2B36J28.USD","LU2210150020.SGD","LU0124676726.USD","INCY","LU1057294990.SGD","LU2210149790.SGD","LU0949170772.SGD","LU1551013342.USD","ORKA","IXJ","LU0965508806.USD","FTXH","LU1923622614.USD","LU0098860793.USD","NDAQ","MEDX","LU0395794307.EUR","JDOC","LU2347655156.SGD","LU2357627491.SGD","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208954","title":"Truist Securities Adjusts Price Target on Hims & Hers Health to $32 From $27, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208954","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208954?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:16","pubTimestamp":1787591793,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) has an average rating of hold and mean price target of $32.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIMC","HIYY","HIMY","THNR","BK4196","HMYY","HIMZ","HEAL","GLAM","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208416","title":"Is AbbVie (ABBV) Fairly Valued As New Lung Cancer Data Impresses?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208416","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208416?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:27","pubTimestamp":1787588879,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) is back in focus after new lung cancer data at the 2026 World Conference on Lung Cancer, where its investigational therapies in both NSCLC and SCLC reported high objective response rates with manageable safety profiles.\nSee our latest analysis for AbbVie.\nThe latest lung cancer data arrives during a strong run for AbbVie, with a 24.32% 90 day share price return and a 31.62% 1 year total shareholder return suggesting that momentum has been building.\nIf this lung cancer update has...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/is-abbvie-abbv-fairly-valued-as-new-lung-cancer-data-impress","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/is-abbvie-abbv-fairly-valued-as-new-lung-cancer-data-impress","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0128525929.USD","LU2468319806.SGD","IYH","PPH","IE00BBT3K403.USD","GLAM","LU0708994859.HKD","LU1989772923.USD","SG9999015945.SGD","FHLC","IE000BZT7R73.USD","IE0002141913.USD","LU0234570918.USD","MEDX","LU0122379950.USD","SG9999001440.SGD","AGNG","LU1061106388.HKD","BK4559","LU0211328371.USD","IE00B19Z3581.USD","ABBV","LU2347655073.USD","LU0726765562.USD","LU1496350502.SGD","LU1057294990.SGD","PJP","LU0170899867.USD","LU0861579265.USD","IE00BFTCPJ56.SGD","LU0868494708.USD","LU1003077747.HKD","FTXH","LU1934455863.HKD","LU0057025933.USD","RXL","LU0310799852.SGD","IXJ","LU1023059063.AUD","IE00B2B36J28.USD","XLV","TRUH","JDOC","LU2357627491.SGD","LU1934455277.USD","LU0234572021.USD","LU1934455194.USD","VHT","LU2237443978.SGD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272481","title":"Hims & Hers’ weight-loss plans draw penalties by Visa, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661272481?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:30","pubTimestamp":1787581813,"startTime":"0","endTime":"0","summary":"Hims & Hers (HIMS) has been placed in Visa’s (V) Acquirer Monitoring Program after a surge in weight-loss subscription disputes, adding scrutiny to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hims-hers-weight-loss-plans-draw-penalties-by-visa-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hims-hers-weight-loss-plans-draw-penalties-by-visa-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJTD4N35.SGD","LU1861220207.SGD","HMYY","LU1228905037.USD","LU0868494708.USD","LU0265550946.USD","SGXZ99366536.SGD","LU0029864427.USD","LU0079474960.USD","LU0354030438.USD","LU1035773651.USD","LU0861579265.USD","LU2471134879.HKD","LU0476273544.USD","FDFF","LU0289739343.SGD","LU0417517546.SGD","THNR","LU2433249047.HKD","IE00B1XK9C88.USD","LU1814569148.SGD","LU1236620834.HKD","LU1934455194.USD","LU1791710400.SGD","LU1989772923.USD","LU0444973449.USD","LU0124676726.USD","LU2360032135.SGD","LU0345774631.USD","V","LU0683600562.USD","LU2404859667.USD","IE00BQXX3D17.EUR","LU2764263039.SGD","IE000WAW04H5.SGD","LU2023250504.SGD","LU1935043023.USD","LU1043141396.HKD","LU0642271901.SGD","LU0823434583.USD","LU0823421333.USD","LU1069347547.HKD","BK4588","IE00BKDWB100.SGD","IE000SO60NU8.SGD","BK4106","LU1642822529.SGD","IYG","LU1670627923.USD","LU1064131342.USD","IPAY","LU0096362180.USD","IE000F7OJYX1.SGD","LU0127658192.USD","LU0133085943.USD","LU1267930573.SGD","IE00B19Z8X17.USD","LU0965509010.AUD","LU2506951875.HKD","LU0994945656.USD","IE0000B7K699.USD","LU2764262908.HKD","LU0348723411.USD","LU1815336760.USD","LU1923622614.USD","LU0708994859.HKD","LU1852331112.SGD","LU1366333091.USD","LU0265550359.USD","LU2125909247.SGD","LU2023250843.SGD","LU0234570918.USD","IE00B1BXHZ80.USD","LU0545562505.USD","LU1935042991.SGD","LU1988902786.USD","LU2023251221.USD","SGXZ51526630.SGD","TRUF","LU2404859741.USD","BK4527","LU1934455277.USD","LU0106261372.USD","LU1791710582.SGD","LU2361044865.SGD","LU2471134952.CNY","LU1363072403.SGD","LU0965508806.USD","IE00BWXC8680.SGD","LU0234572021.USD","LU0170899867.USD","IE00B19Z8W00.USD","LU1400636657.SGD","LU2089284900.SGD","LU2028103732.USD","SG9999014880.SGD","LU0057025933.USD","LU1974910355.USD","LU1803068979.SGD","LU1202635105.USD","LU2750360641.GBP","LU2264538146.SGD","LU2471134523.USD","LU0256863811.USD","LU0444971666.USD","LU1989772840.SGD","LU1035775433.USD","LU1069344957.HKD","LU0215105999.USD","LU0289941410.SGD","LU0965509101.SGD","LU1815333072.USD","LU0289961442.SGD","LU0069063385.USD","LU0426417589.USD","LU1934455863.HKD","BK4535","LU0353189763.USD","LU0823417737.USD","LU2125154778.USD","SG9999018865.SGD","LU2506952170.USD","LU2097829019.USD","SG9999017495.SGD","LU0006306889.USD","SG9999000418.SGD","LU0942090050.USD","LU2242649171.HKD","LU0097036916.USD","LU0472753341.HKD","LU1623119135.USD","LU1691799644.USD","LU1037948897.HKD","LU0672654240.SGD","IE00BJTD4V19.USD","IE000BZT7R73.USD","LU1228905540.USD","HEAL","LU0528227936.USD","LU0640476718.USD","LU2244417387.USD","GB00B4LPDJ14.GBP","HIMZ","LU0957808578.USD","LU0345774391.USD","LU1267930730.SGD","LU0690374961.EUR","IE00B19Z9505.USD","LU1670756490.USD","HIMS","LU1935043536.SGD","LU1232071149.USD","LU0557290698.USD","LU0158827781.USD","LU0689626769.HKD","LATR","LU2106854487.HKD","LU2746668461.USD","LU2750360997.AUD","LU0251132253.USD","LU2361044949.HKD","LU0048584097.USD","LU2237438978.USD","LU2764263203.CNY","UYG","LU0823421416.USD","FNCL","IE00BKVL7J92.USD","IE00BQXX3F31.USD","LU1917777945.USD","BK4534","LU1435385759.SGD","LU2125909593.SGD","LU0056508442.USD","LU0289960550.SGD","LU1712237335.SGD","LU0316494557.USD","SG9999014906.USD","LU0175139822.USD","LU0342679015.USD","LU0823417653.USD","BK4598","LU1429558221.USD","LU1935042488.USD","LU2506951958.HKD","LU0868494617.USD","LU0109391861.USD","LU1046421795.USD","VFH","LU0390134368.USD","LU1316542783.SGD","LU1116320901.HKD","GB00B4QBRK32.GBP","LU0353189680.USD","XLF","LU1116320737.USD","LU1633808545.USD","IE00BZ1G4Q59.USD","LU2720916845.USD","LU1935042215.USD","SG9999014898.SGD","LU2506952097.USD","LU0823434740.USD","BK4227","LU0320765059.SGD","SG9999014914.USD","LU0957791311.USD","LU2125154935.USD","TFNS","IE00BQXX3C00.GBP","BK4585","IXG","LU0354030511.USD","LU1043141123.HKD","LU2087625088.SGD","LU0158827948.USD","LU0187121727.USD","LU1823568750.SGD","LU2461242641.AUD","LU0971096721.USD","LU2326559502.SGD","LU1400636574.HKD","LU2111349929.HKD","LU0690374615.EUR","LU1400636491.USD","LU0109392836.USD","LU0128525929.USD","LU1670628061.USD","LU2360107671.USD","LU0426412945.USD","LU1280957306.USD","LU0154236417.USD","LU0511384066.AUD","LU1861217088.USD","SGXZ81514606.USD","LU1979441026.SGD","HIMC","LU0157215616.USD","SGXZ31699556.SGD","BK4559","IE000MB6IJN5.SGD","LU2462591350.SGD","LU0061474960.USD","LU0787776722.HKD","LU1121112475.USD","LU2471134796.USD","SG9999018857.SGD","BK4196","GLAM","LU0950375773.USD","LU0174119429.USD","LU1804176565.USD","LU2271345857.HKD","HIYY","LU0708995401.HKD","LU0225283273.USD","LU1645745479.HKD","BK4533","LU2361045086.USD","LU2089283258.USD","LU0965509283.SGD","LU2746668974.SGD","LU1037948541.HKD","BK4581","SG9999001424.SGD","LU1236620750.USD","HIMY","LU2265009873.SGD","LU0256863902.USD","LU0310800379.SGD","LU0889565833.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661780652","title":"ANI Pharma Appoints Henry Gosebruch to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661780652","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661780652?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:55","pubTimestamp":1787568930,"startTime":"0","endTime":"0","summary":"ANI Pharma appoints Henry Gosebruch to board of directorsANI Pharmaceuticals appointed Henry Gosebruch to its board, effective Aug. 19, 2026.Gosebruch has been CEO of Lakefront Biotherapeutics NV sinc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL5nczHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU0661504455.SGD","IE000WAW04H5.SGD","LU2210150020.SGD","IE00BKPKM429.USD","FHLC","BK4588","LU1037948897.HKD","LU1430594728.SGD","IYH","SG9999014013.SGD","PPH","PJP","LU1718418525.SGD","XLV","NMRA","JDOC","NDAQ","TRUH","AGNG","LU0128525929.USD","LU0069063385.USD","LU2089283258.USD","LU0689626769.HKD","LU1670627923.USD","IXJ","IE00B2B36J28.USD","LU1023059063.AUD","LU0314104364.USD","LU2129689514.USD","MEDX","BK4585","FTXH","RXL","ANIP","VHT","LU0158827948.USD","BCDF","LU0395794307.EUR","GLAM","LU0868494617.USD","IE00BBT3K403.USD","IE00BN0W2W23.USD","LU0511384066.AUD","LU0211328371.USD","LU0738911758.USD","LU1989772840.SGD","ABBV","LU0417517546.SGD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290992","title":"EstÉE Lauder : Berenberg Raises Target Price to $92 from $84","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290992","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290992?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:11","pubTimestamp":1787559066,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44K01P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU1988902786.USD","LU0690374615.EUR","LU0690374961.EUR","BK4183","EL","LU2264538146.SGD","BK4558","BK4548","LU1064131342.USD","LU2552382058.USD","GLAM","BK4533","LU2552382132.HKD","LU2552382215.SGD","LU2404859667.USD","BK4585","LU2404859741.USD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217334","title":"Hims & Hers (HIMS) Stock Looks Like A Bargain After A 396% Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217334","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217334?lang=en_us&edition=fundamental","pubTime":"2026-08-23 09:23","pubTimestamp":1787448214,"startTime":"0","endTime":"0","summary":"Hims & Hers Health has delivered a very large 3 year gain for shareholders, yet the latest valuation work suggests the stock still trades at a discount to its estimated intrinsic value. With fresh headlines around AI in healthcare, peptide therapies and regulatory scrutiny, the big question for investors is how much of that story is already in the price.\n\nThe stock has returned about 396% over the past 3 years, which puts a lot of focus on whether the current share price can still be...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-hims-stock-looks-like-a-bargain-after-a-396-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-hims-stock-looks-like-a-bargain-after-a-396-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HIMS","HIYY","HIMY","THNR","HIMZ","HMYY","BK4196","GLAM","HIMC","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661199722","title":"Johnson & Johnson, AbbVie, Chevron, Energy Transfer, Home Depot Shaken","url":"https://stock-news.laohu8.com/highlight/detail?id=2661199722","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661199722?lang=en_us&edition=fundamental","pubTime":"2026-08-22 21:00","pubTimestamp":1787403639,"startTime":"0","endTime":"0","summary":"Insiders have been trading these 5 stocks: (($JNJ)), (($ABBV)), (($CVX)), (($ET)) and (($HD)). Here is a breakdown of their recent trades and their...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/johnson-johnson-abbvie-chevron-energy-transfer-home-depot-shaken?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/johnson-johnson-abbvie-chevron-energy-transfer-home-depot-shaken?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTXN","ABBV","FTXH","HD","JNJ","WEEI","GDOC","IXJ","DRLL","JDOC","IYH","XLE","BK4532","GXPE","IE000BZT7R73.USD","PJP","PPH","IGE","IXC","LU0203347892.USD","GLAM","FENY","HOMZ","XLV","FHLC","CVX","MEDX","VHT","LU0640476718.USD","RXL","BK4568","LU2602419157.SGD","LU1228905540.USD","ERX","LU2461242641.AUD","IHE","DIG","RTH","IYE","LU1145028129.USD","VDE","BK4592","LU1244550494.USD","PKB","TRUN","TEXU","TRUH","IE00BWXC8680.SGD","AGNG","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972218","title":"Market Chatter: Hims & Hers Health Faces Nearly $75,000 Bill From Card Disputes","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972218","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972218?lang=en_us&edition=fundamental","pubTime":"2026-08-22 06:27","pubTimestamp":1787351270,"startTime":"0","endTime":"0","summary":"Hims & Hers Health  was placed on notice by Visa for excessive customer complaints in its weight-loss subscription business, Bloomberg reported Friday, citing internal documents.The company was enrolled in Visa's Acquirer Monitoring Program after a surge in credit card disputes in July, with each dispute carrying an $8 surcharge that will result in a bill of nearly $75,000 in September, the report said, citing the documents.Hims was notified of its placement by payment processor Stripe earlier this month and must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program, according to the documents, Bloomberg reported.A Hims spokesperson said the company has seen \"a relatively small number of disputed charges\" and has taken steps to address it, adding that its checkout process is clear about membership and medication costs, the report said.Hims & Hers Health did not immediately respond to a request for comment from MT Newswires.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HIMC","GLAM","HIYY","THNR","HEAL","HIMS","HMYY","HIMY","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661297296","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2661297296","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661297296?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:31","pubTimestamp":1787344260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  advanced 1.20% to $264.96 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.43% to 7,674.37 and the Dow Jones Industrial Average  rising 0.98% to 53,277.01.AbbVie Inc. closed 0.94% below its 52-week high of $267.47, which the company achieved on July 29th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 1.07% to $270.24, Pfizer Inc.  rose 1.01% to $28.07, and Amgen Inc.  rose 1.88% to $439.33.Trading volume  remained 1.8 million below its 50-day average volume of 7.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU1989772840.SGD","LU1074936037.SGD","LU1267930490.SGD","LU1430594728.SGD","BK4533","LU0289739699.SGD","AGNG","LU1244550221.USD","LU1162221912.USD","LU0943347566.SGD","IXJ","LU0965509010.AUD","IE00B19Z3B42.SGD","LU0395794307.EUR","LU2433249047.HKD","LU2089283258.USD","LU1291159041.SGD","IE00B42XCP33.USD","IE00BVYPNW00.USD","IE00BGHQF631.EUR","LU0320765646.SGD","MEDX","LU2125909247.SGD","LU0868494617.USD","SG9999015952.SGD","LU2087621335.USD","LU1551013425.SGD","LU1718418525.SGD","BK4566","LU0511384066.AUD","GLAM","SG9999003800.SGD","LU0942090050.USD","LU0861579265.USD","LU0122379950.USD","LU2237443622.USD","IE000WAW04H5.SGD","IE00BLSP4239.USD","LU0726765562.USD","LU2089284900.SGD","FHLC","LU2357627491.SGD","LU0170899867.USD","ABBV","LU2347655073.USD","LU2347655156.SGD","BK4534","LU0211328371.USD","SG9999015978.USD","LU0198837287.USD","LU2125909593.SGD","FTXH","LU0965509283.SGD","LU2129689605.HKD","LU0985320562.USD","LU1023059063.AUD","LU0661504455.SGD","LU0158827948.USD","LU0058720904.USD","LU0432979614.USD","LU0738911758.USD","LU0795875169.SGD","IYH","LU0965509101.SGD","LU0820561909.HKD","LU1934455863.HKD","LU0057025933.USD","LU1496350502.SGD","BK4581","LU0203347892.USD","IE00B3PB1722.GBP","LU1093756325.SGD","LU0823416689.USD","LU0949170772.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1585245621.USD","LU1929549753.HKD","LU2237443382.USD","LU0256863902.USD","LU0098860793.USD","LU0289739343.SGD","IE0000B7K699.USD","LU0289961442.SGD","LU0310799852.SGD","LU1551013342.USD","LU2089984988.USD","IE000MB6IJN5.SGD","LU1093756168.USD","TRUH","IE00BSNM7G36.USD","LU0234570918.USD","LU1244550577.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU1670627923.USD","LU0256863811.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU0114720955.EUR","LU2133065610.SGD","LU1267930573.SGD","LU2112291526.USD","IE0004445239.USD","LU1003077747.HKD","LU0795875086.SGD","LU2129689431.USD","LU0708994859.HKD","IE0002270589.USD","LU2468319806.SGD","LU0069063385.USD","IE00BDGV0183.EUR","LU0417517546.SGD","IE00BLSP4452.SGD","LU1732799900.SGD","LU0124676726.USD","LU2237443978.SGD","IE00BJJMRZ35.SGD","LU0203345920.USD","IE00BBT3K403.USD","LU1839511570.USD","LU1670628061.USD","BK4550","SG9999001440.SGD","IE000BZT7R73.USD","LU0912757837.SGD","LU0553294199.USD","LU2237443549.SGD","SG9999011175.SGD","VHT","LU0456855351.SGD","LU0545039389.USD","LU0859254822.USD","LU0965508806.USD","LU1244550494.USD","LU0310800379.SGD","LU1037948897.HKD","LU2023251221.USD","BK4585","IE000F7OJYX1.SGD","LU1989772923.USD","LU2129689514.USD","IE0009355771.USD","LU1934455277.USD","IE00BN8TJ469.HKD","PPH","LU1989771016.USD","LU0868494708.USD","IE000SO60NU8.SGD","BK4559","JDOC","LU1923622614.USD","LU0472753341.HKD","LU1934455194.USD","LU0211327993.USD","IE00B2B36J28.USD","PJP","LU0234572021.USD","LU1496350171.SGD","IE00B19Z3581.USD","IE00BVYPNV92.GBP","LU0029864427.USD","LU1057294990.SGD","LU2237443895.HKD","RXL","LU2237443465.HKD","SG9999015945.SGD","SG9999015986.USD","BK4588","LU0689472784.USD","LU1732800096.USD","BK4139","LU0820561818.USD","LU1037948541.HKD","XLV","LU1061106388.HKD","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291072","title":"AbbVie Expands Aesthetics Pipeline With New Phase 2 Forehead Lines Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291072","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291072?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:33","pubTimestamp":1787330012,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is running a Phase 2 study called “A Phase 2 Open-Label Study to Evaluat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-expands-aesthetics-pipeline-with-new-phase-2-forehead-lines-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-expands-aesthetics-pipeline-with-new-phase-2-forehead-lines-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999003800.SGD","IE00BSNM7G36.USD","IE0002270589.USD","IE0009355771.USD","RXL","IE00B42XCP33.USD","LU0198837287.USD","LU0158827948.USD","LU1291159041.SGD","IE0004445239.USD","LU0965509101.SGD","SG9999015952.SGD","PPH","IE000SO60NU8.SGD","LU0943347566.SGD","TRUH","IE00BLSP4239.USD","LU0868494617.USD","LU2347655073.USD","LU0545039389.USD","IXJ","ABBV","LU0661504455.SGD","LU0859254822.USD","SG9999011175.SGD","LU0708994859.HKD","LU2125909593.SGD","LU1585245621.USD","LU0122379950.USD","IYH","LU0965509283.SGD","PJP","FTXH","IE00BFTCPJ56.SGD","LU2237443622.USD","LU2089284900.SGD","MEDX","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1934455194.USD","AGNG","LU2023251221.USD","VHT","LU0128525929.USD","LU0170899867.USD","XLV","JDOC","FHLC","LU0965509010.AUD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294839","title":"AbbVie Targets Pediatric Alopecia With New Phase 3 Trial: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661294839?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:31","pubTimestamp":1787329917,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. The Phase 3 study “A Phase 3 Randomized, Placebo-controlled, Double-blind Study...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-pediatric-alopecia-with-new-phase-3-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-pediatric-alopecia-with-new-phase-3-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","LU2237443895.HKD","ABBV","LU1244550577.SGD","IE00BBT3K403.USD","LU0545039389.USD","TRUH","LU2237443978.SGD","JDOC","LU2089284900.SGD","LU0689626769.HKD","LU0456855351.SGD","LU2125909593.SGD","LU0868494617.USD","LU0820561818.USD","LU1934455277.USD","LU0861579265.USD","IE00B19Z3B42.SGD","LU0417517546.SGD","PJP","LU2129689514.USD","XLV","IYH","AGNG","LU0395794307.EUR","LU1989771016.USD","LU2237443549.SGD","IE00BGHQF631.EUR","IXJ","RXL","LU1496350171.SGD","BK4139","LU0795875169.SGD","IE00BN8TJ469.HKD","LU0912757837.SGD","FHLC","LU0823416689.USD","GLAM","IE00B42XCP33.USD","VHT","LU0949170772.SGD","LU0689472784.USD","LU1989772840.SGD","LU1989772923.USD","MEDX","FTXH","PPH","LU0122379950.USD","LU2433249047.HKD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294820","title":"AbbVie’s Emraclidine Schizophrenia Study Ends Early: What Investors Need to Know Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294820","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661294820?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:30","pubTimestamp":1787329825,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie’s long-term Phase 2 trial NCT05443724, titled “A 52-week, Phase 2, Open-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-emraclidine-schizophrenia-study-ends-early-what-investors-need-to-know-now?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-emraclidine-schizophrenia-study-ends-early-what-investors-need-to-know-now?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","JDOC","IE00B19Z3B42.SGD","AGNG","MEDX","LU1929549753.HKD","LU0689626769.HKD","GLAM","LU0256863811.USD","BK4550","LU0943347566.SGD","IE00B4R5TH58.HKD","LU0234570918.USD","LU1989772840.SGD","PSIL","LU2237443895.HKD","IE00BN8TJ469.HKD","LU1003077747.HKD","LU1093756168.USD","FTXH","LU0708994859.HKD","LU2023251221.USD","IE0004445239.USD","LU0310799852.SGD","LU0432979614.USD","LU0861579265.USD","VHT","PJP","ISBC","RXL","IXJ","LU1267930490.SGD","LU0029864427.USD","LU0158827948.USD","IYH","LU1934455863.HKD","XLV","LU1551013342.USD","TRUH","LU0795875086.SGD","ABBV","IE000F7OJYX1.SGD","LU1244550494.USD","PPH","BBC","BK4534","SG9999003800.SGD","SG9999001440.SGD","BK4588","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661329186","title":"Estee Lauder is Maintained at Equal-Weight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2661329186","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661329186?lang=en_us&edition=fundamental","pubTime":"2026-08-21 23:37","pubTimestamp":1787326620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EL/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382058.USD","BK4504","LU2552382132.HKD","GLAM","LU2404859667.USD","LU0690374961.EUR","LU1064131342.USD","EL","BK4533","BK4585","BK4558","BK4588","LU1988902786.USD","LU0690374615.EUR","LU2264538146.SGD","LU2552382215.SGD","BK4548","BK4183","LU2404859741.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661994452","title":"Estée Lauder Announces Q3 2026 Distribution of R$ 0.05 Per Unit, Payable Sept. 21","url":"https://stock-news.laohu8.com/highlight/detail?id=2661994452","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661994452?lang=en_us&edition=fundamental","pubTime":"2026-08-21 23:16","pubTimestamp":1787325410,"startTime":"0","endTime":"0","summary":"Estée Lauder announces Q3 2026 distribution of R$ 0.05 per unit, payable Sept. 21Estée Lauder announced a 3Q 2026 distribution of R$ 0.05 per unit for BRELCIBDR 007.Last day to trade with entitlement ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLbbR7kw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4558","LU2552382132.HKD","BK4548","GLAM","LU2404859667.USD","LU0690374615.EUR","LU2404859741.USD","EL","BK4504","LU0690374961.EUR","BK4183","LU2264538146.SGD","LU1064131342.USD","LU1988902786.USD","LU2552382058.USD","BK4585","BK4588","LU2552382215.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661595332","title":"Hims & Hers Health (HIMS) Lifts Guidance As Scrutiny Builds, Is The Stock Fully Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661595332","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661595332?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:18","pubTimestamp":1787275129,"startTime":"0","endTime":"0","summary":"Hims & Hers Health (HIMS) is back in the spotlight after reporting strong year over year revenue growth and raising its 2026 sales outlook, even as fresh regulatory and legal actions intensify scrutiny of its telehealth model.\nSee our latest analysis for Hims & Hers Health.\nOver the past year, Hims & Hers Health has combined strong revenue updates, raised 2026 sales guidance and a string of regulatory headlines, with the stock showing a 34.15% 90 day share price return but a 27.52% decline in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-lifts-guidance-as-scrutiny-builds-is-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-lifts-guidance-as-scrutiny-builds-is-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HIMS","GLAM","HIMZ","BK4196","HEAL","HMYY","THNR","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232124","title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of USD 691,808 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232124","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232124?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:30","pubTimestamp":1787257857,"startTime":"0","endTime":"0","summary":"Hims & Hers Chief Legal Officer Soleil Boughton disposes of USD 691,808 in common sharesHims & Hers Health Chief Legal Officer Soleil Boughton sold 25,111 Class A common shares on Aug. 19, 2026.Sale p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDLjmkJy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of USD 691,808 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","BK4196","HEAL","GLAM","HIMZ","THNR","HIMS","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661369852","title":"AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661369852","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661369852?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:32","pubTimestamp":1787243542,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is launching a Phase 1 study called “A Phase 1 Study to Evaluate ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-next-gen-botox-combo-with-new-glabellar-lines-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-next-gen-botox-combo-with-new-glabellar-lines-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1244550221.USD","IE00BN8TJ469.HKD","LU1430594728.SGD","IYH","PPH","IE00BBT3K403.USD","GLAM","FHLC","LU1162221912.USD","BK4581","LU0211327993.USD","BK4533","IE0009355771.USD","LU0234570918.USD","MEDX","SG9999001440.SGD","AGNG","IE00BDGV0183.EUR","LU0203347892.USD","LU1923622614.USD","ABBV","LU2347655073.USD","BK4534","IE00BVYPNV92.GBP","LU2347655156.SGD","LU1291159041.SGD","PJP","LU0170899867.USD","IE00BFTCPJ56.SGD","FTXH","LU1934455863.HKD","IE000MB6IJN5.SGD","LU0057025933.USD","RXL","LU2087621335.USD","IXJ","LU0943347566.SGD","LU0965508806.USD","LU1023059063.AUD","IE00B2B36J28.USD","LU1074936037.SGD","LU2089284900.SGD","LU0417517546.SGD","TRUH","JDOC","XLV","LU1934455194.USD","VHT","LU2237443978.SGD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660666235","title":"Estee Lauder's Fiscal 2027 Guidance Achievable as Turnaround Continues, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660666235","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660666235?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:43","pubTimestamp":1787240617,"startTime":"0","endTime":"0","summary":"Estee Lauder's (EL) turnaround continues to progress and its fiscal 2027 guidance is achievable, RBC Capital Market said in a Thursday note.The company's fiscal Q4 results showed that its income state","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0690374961.EUR","EL","BK4558","BK4533","LU2264538146.SGD","LU2404859667.USD","BK4183","LU1064131342.USD","LU1988902786.USD","BK4585","LU0690374615.EUR","LU2552382132.HKD","LU2552382215.SGD","LU2552382058.USD","LU2404859741.USD","BK4548","BK4588","GLAM","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660235503","title":"Estée Lauder Analysts Boost Their Forecasts After Better-Than-Expected Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660235503","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660235503?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:43","pubTimestamp":1787240581,"startTime":"0","endTime":"0","summary":"Estee Lauder (EL) reported strong Q4 results and raised FY27 sales guidance, with adjusted earnings beating estimates. Analysts have raised price targets.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61335183/estee-lauder-analysts-boost-their-forecasts-after-better-than-expected-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","BK4558","LU2552382215.SGD","EL","RGLO","LU1988902786.USD","BK4548","LU2404859667.USD","BK4585","BK4533","LU1064131342.USD","LU2552382132.HKD","LU2552382058.USD","BK4588","LU2264538146.SGD","GLAM","BK4504","LU2404859741.USD","LU0690374961.EUR","LU0690374615.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}